Patents by Inventor Juliette BEN AROUS

Juliette BEN AROUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX
    Publication number: 20230052315
    Abstract: Disclosed is a vaccine adjuvant including at least one inverse microlatex, the inverse microlatex including at least one oil, at least one surfactant, at least one polymer such as, for example, a polyacrylate that is totally or partially neutralized in the form of alkali metal salts or ammonium salt, the vaccine adjuvant being entirely sterilizable by filtration or by passing through the heat of an autoclave and emulsifiable in one step with the aqueous phase including only a vaccine antigen.
    Type: Application
    Filed: February 17, 2021
    Publication date: February 16, 2023
    Inventors: Dorothee PLISZCZAK, Juliette BEN AROUS, Stéphane MONTEILLET, David PUJOL
  • Oral administration of at least one pharmaceutical and/or antigenic active substance
    Patent number: 10238737
    Abstract: Disclosed is a gastro-resistant vector for the oral administration of at least one pharmaceutical and/or antigenic active substance including an aqueous phase (W) and an oily phase (O) in the form of a water-in-oil (W/O)-type emulsion wherein the aqueous phase includes at least one active principle and between 2 and 40 wt. % of a hydrophilic polymer that is insoluble in an aqueous phase of pH<6.5.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: March 26, 2019
    Assignee: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
    Inventors: Juliette Ben Arous, Laurent Dupuis, Jerome Gaucheron
  • Adjuvanted vaccines for in ovo avian vaccination
    Patent number: 9889196
    Abstract: A composition includes at least one mineral oil, a surfactant having a hydrophilic property characterized by an HLB value equal to 12 and a divalent inorganic salt intended to be used as an adjuvant in a vaccine composition for the in ovo vaccination of avian species wherein the composition is an oil-in-water emulsion or microemulsion.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: February 13, 2018
    Assignee: SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIED CHIMIQUES SEPPIC
    Inventors: Juliette Ben Arous, Laurent Dupuis, Hyun Lillehoj
  • ORAL ADMINISTRATION OF AT LEAST ONE PHARMACEUTICAL AND/OR ANTIGENIC ACTIVE SUBSTANCE
    Publication number: 20170281755
    Abstract: Disclosed is a gastro-resistant vector for the oral administration of at least one pharmaceutical and/or antigenic active substance including an aqueous phase (W) and an oily phase (O) in the form of a water-in-oil (W/O)-type emulsion wherein the aqueous phase includes at least one active principle and between 2 and 40 wt. % of a hydrophilic polymer that is insoluble in an aqueous phase of pH<6.5.
    Type: Application
    Filed: September 7, 2015
    Publication date: October 5, 2017
    Inventors: Juliette BEN AROUS, Laurent DUPUIS, Jerome GAUCHERON
  • ADJUVANTED VACCINES FOR IN OVO AVIAN VACCINATION
    Publication number: 20160256544
    Abstract: A composition includes at least one mineral oil, a surfactant having a hydrophilic property characterised by an HLB value equal to 12 and a divalent inorganic salt intended to be used as an adjuvant in a vaccine composition for the in ovo vaccination of avian species wherein the composition is an oil-in-water emulsion or microemulsion.
    Type: Application
    Filed: November 12, 2014
    Publication date: September 8, 2016
    Inventors: Juliette BEN AROUS, Laurent DUPUIS, Hyun LILLEHOJ